Concepts of Regional Therapies for Advanced Malignancy T. Clark GamblinH. Richard AlexanderDavid L. Bartlett Regional Cancer Therapies 03 February 2012 Pages: 1371 - 1372
Quality of Life Outcomes after Isolated Limb Infusion Rebecca J. McClaineJoseph S. GigliaJeffrey J. Sussman Regional Cancer Therapies 03 February 2012 Pages: 1373 - 1378
Importance of Histologic Subtype in the Staging of Appendiceal Tumors Kiran K. TuragaSam G. PappasT. Clark Gamblin Regional Cancer Therapies 03 February 2012 Pages: 1379 - 1385
Aggressive Management of Peritoneal Carcinomatosis from Mucinous Appendiceal Neoplasms Frances AustinArun MavanurHaroon A. Choudry Regional Cancer Therapies 03 February 2012 Pages: 1386 - 1393
Combined Diffusion-Weighted and Gadolinium-Enhanced MRI Can Accurately Predict the Peritoneal Cancer Index Preoperatively in Patients Being Considered for Cytoreductive Surgical Procedures Russell N. LowRobert M. Barone Regional Cancer Therapies 03 February 2012 Pages: 1394 - 1401
Chronic Anti-inflammatory Drug Therapy Inhibits Gel-Forming Mucin Production in a Murine Xenograft Model of Human Pseudomyxoma Peritonei Haroon Asif ChoudryArun MavanurDavid L. Bartlett Regional Cancer Therapies 03 February 2012 Pages: 1402 - 1409
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Sarcomatosis George I. SaltiLuay AilabouniSamir Undevia Regional Cancer Therapies 03 February 2012 Pages: 1410 - 1415
Cytoreductive Surgery with Selective Versus Complete Parietal Peritonectomy Followed by Hyperthermic Intraperitoneal Chemotherapy in Patients with Diffuse Malignant Peritoneal Mesothelioma: A Controlled Study Dario BarattiShigeki KusamuraMarcello Deraco Regional Cancer Therapies 03 February 2012 Pages: 1416 - 1424
The Role of Adjuvant Chemotherapy for Localized Squamous Cell Esophageal Cancer: Current Japanese Standard and the Unending Role of the Drawing Board Yuko KitagawaNobutoshi AndoHaruhiko Fukuda Thoracic Oncology 07 March 2012 Pages: 1425 - 1427
Management of Patients with Primary Hyperparathyroidism and Concurrent Thyroid Disease: An Evolving Field Philip M. SpanheimerRonald J. Weigel Endocrine Tumors 07 March 2012 Pages: 1428 - 1429
Adverse Effects of Smoking on Postoperative Outcomes in Cancer Patients Csaba GajdosMary T. HawnThomas Houston Healthcare Policy and Outcomes 08 November 2011 Pages: 1430 - 1438
A Population-Based Comparison of Adenocarcinoma of the Large and Small Intestine: Insights Into a Rare Disease Michael J. OvermanChung-Yuan HuGeorge J. Chang Healthcare Policy and Outcomes 21 December 2011 Pages: 1439 - 1445
Thyroid Cancer Detection with Dual-isotope Parathyroid Scintigraphy in Primary Hyperparathyroidism Edwin O. OnkendiMelanie L. RichardsClive S. Grant Endocrine Tumors 07 March 2012 Pages: 1446 - 1452
Regional Recurrence after Lymphadenectomy for Clinically Evident Lymph Node Metastases from Papillary Thyroid Cancer: A Cohort Study Parth K. ShahKinjal K. ShahDouglas L. Fraker Endocrine Tumors 13 September 2011 Pages: 1453 - 1459
Patient Factors Affecting Operative Times for Single-incision Trans-Axillary Robotic-assisted (STAR) Thyroid Lobectomy: Does Size Matter? Christina E. StevensonDavid F. GardnerAmelia C. Grover Endocrine Tumors 14 September 2011 Pages: 1460 - 1465
Cinacalcet (Sensipar) Provides no Measurable Clinical Benefits for Patients with Primary Hyperparathyroidism and may Accelerate Bone Loss with Prolonged Use James NormanJose LopezDoug Politz Endocrine Tumors 16 September 2011 Pages: 1466 - 1471
Is One Benign Fine Needle Aspiration Enough? Victoriya S. ChernyavskyBeth-Ann ShankerStanley Z. Trooskin Endocrine Tumors 04 October 2011 Pages: 1472 - 1476
Six-Year Analysis of Treatment-Related Toxicities in Patients Treated with Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial A. J. KhanDouglas ArthurB. G. Haffty Breast Oncology 23 November 2011 Pages: 1477 - 1483
Clinical and Self Breast Examination Remain Important in the Era of Modern Screening Irene MaAmylou DueckBarbara Pockaj Breast Oncology 08 December 2011 Pages: 1484 - 1490
Scoring System Based on BI-RADS Lexicon to Predict Probability of Malignancy in Suspicious Microcalcifications Ji Hyun YoukEun Ju SonEun-Kyung Kim Breast Oncology 16 December 2011 Pages: 1491 - 1498
Loss of Heterozygosity at BRCA1 Locus Is Significantly Associated with Aggressiveness and Poor Prognosis in Breast Cancer Satoko OkadaEriko TokunagaYoshihiko Maehara Breast Oncology 17 December 2011 Pages: 1499 - 1507
Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer Manfred KaufmannGunter von MinckwitzLajos Pusztai Breast Oncology 23 December 2011 Pages: 1508 - 1516
Impact of Race/Ethnicity on Prognosis in Patients Who Underwent Surgery for Colon Cancer: Analysis for White, African, and East Asian Americans Yojiro HashiguchiKazuo HaseHidetaka Mochizuki Colorectal Cancer 20 October 2011 Pages: 1517 - 1528
The Predictive Effect of Cadherin-17 on Lymph Node Micrometastasis in pN0 Gastric Cancer Jin WangJian-Chun YuPei Gu Gastrointestinal Oncology 19 October 2011 Pages: 1529 - 1534
Carcinoma of the Ampulla of Vater: Patterns of Failure Following Resection and Benefit of Chemoradiotherapy Manisha PaltaPretesh PatelBrian Czito Gastrointestinal Oncology 02 November 2011 Pages: 1535 - 1540
Diagnostic Value of Sentinel Lymph Node Biopsy in Gastric Cancer: A Meta-Analysis Zhen WangZhi-Yong DongJin-Lu Liu Gastrointestinal Oncology 03 November 2011 Pages: 1541 - 1550
Patterns of Care, Prognosis, and Survival in Patients with Metastatic Gastrointestinal Stromal Tumors (GIST) Refractory to First-Line Imatinib and Second-Line Sunitinib Antoine ItalianoAngela CioffiBinh Bui Gastrointestinal Oncology 08 November 2011 Pages: 1551 - 1559
DOK2 as a Marker of Poor Prognosis of Patients with Gastric Adenocarcinoma After Curative Resection Hiromichi MiyagakiMakoto YamasakiYuichiro Doki Gastrointestinal Oncology 01 December 2011 Pages: 1560 - 1567
Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy Toru AoyamaTakaki YoshikawaAkira Tsuburaya Gastrointestinal Oncology 06 December 2011 Pages: 1568 - 1574
Endoscopic Therapy for Barrett’s Esophagus: A Review of Its Emerging Role in Optimal Diagnosis and Endoluminal Therapy Erik M. Dunki-JacobsRobert C. G. Martin Gastrointestinal Oncology 13 December 2011 Pages: 1575 - 1582
Comparison of Single-Port Laparoscopy, Standard Laparoscopy, and Robotic Surgery in Patients with Endometrial Cancer Pedro F. EscobarMichael FrumovitzPedro T. Ramirez Gynecologic Oncology 15 November 2011 Pages: 1583 - 1588
Laparoscopic Staging of Early Ovarian Cancer: Results of a Multi-Institutional Cohort Study Fabio GhezziMario MalzoniMassimo Franchi Gynecologic Oncology 16 November 2011 Pages: 1589 - 1594
Lymphatic Vessels and High Endothelial Venules are Increased in the Sentinel Lymph Nodes of Patients with Oral Squamous Cell Carcinoma Before the Arrival of Tumor Cells Man Ki ChungIn-Gu DoChung-Hwan Baek Head and Neck Oncology 29 November 2011 Pages: 1595 - 1601
Oncological Superiority of Hilar En Bloc Resection for the Treatment of Hilar Cholangiocarcinoma Peter NeuhausArmin ThelenDaniel Seehofer Hepatobiliary Tumors 01 October 2011 Pages: 1602 - 1608
Biliary Sclerosis after Hepatic Arterial Infusion Pump Chemotherapy for Patients with Colorectal Cancer Liver Metastasis: Incidence, Clinical Features, and Risk Factors Kaori ItoHiromichi ItoMichael I. D’Angelica Hepatobiliary Tumors 12 October 2011 Pages: 1609 - 1617
Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy Ninos AyezZarina S. LalmahomedCornelis Verhoef Hepatobiliary Tumors Open access 18 October 2011 Pages: 1618 - 1627
Combined Hepatocellular–Cholangiocarcinoma Had Poor Outcomes after Hepatectomy Regardless of Allen and Lisa Class or the Predominance of Intrahepatic Cholangiocarcinoma Cells within the Tumor Shun-ichi AriizumiYoshihito KoteraMasakazu Yamamoto Hepatobiliary Tumors 24 November 2011 Pages: 1628 - 1636
A Multi-institutional Experience of Repeat Regional Chemotherapy for Recurrent Melanoma of Extremities Christy Y. ChaiJeremiah L. DeneveJonathan S. Zager Melanomas 06 December 2011 Pages: 1637 - 1643
Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies Angelo AndriulliVirginia FestaPierluigi Di Sebastiano Pancreatic Tumors 20 October 2011 Pages: 1644 - 1662
Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease K. A. BickenbachM. GonenP. J. Allen Pancreatic Tumors 01 December 2011 Pages: 1663 - 1669
Surveillance of Pancreatic Cancer Patients after Surgical Resection Kristin M. SheffieldKristen T. CrowellTaylor S. Riall Pancreatic Tumors 06 December 2011 Pages: 1670 - 1677
Pathologic Nonresponders after Neoadjuvant Chemoradiation for Esophageal Cancer Demonstrate no Survival Benefit Compared with Patients Treated with Primary Esophagectomy George W. DittrickJill M WeberKenneth L. Meredith Thoracic Oncology 02 November 2011 Pages: 1678 - 1684
Changes in Age, Stage Distribution, and Survival of Patients with Esophageal Adenocarcinoma over Three Decades in the United States Putao CenFarzaneh BankiLarry R. Kaiser Thoracic Oncology 01 December 2011 Pages: 1685 - 1691
Clinical Impact of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma Vincenzo AmbrogiAlfonso BaldiTommaso Claudio Mineo Thoracic Oncology 23 December 2011 Pages: 1692 - 1699
Clinicopathological Significance of ZEB1 Protein in Patients with Hepatocellular Carcinoma Yan-Ming ZhouLu CaoJia-Mei Yang Translational Research and Biomarkers 17 May 2011 Pages: 1700 - 1706
Serum HE4 Level is an Independent Prognostic Factor in Epithelial Ovarian Cancer Sun-Young KongMi Hwa HanSokbom Kang Translational Research and Biomarkers 21 July 2011 Pages: 1707 - 1712
The Immunological Impact of Neoadjuvant Chemotherapy on the Tumor Microenvironment of Esophageal Squamous Cell Carcinoma Takahiro TsuchikawaMasaki Miyamoto MDSatoshi Kondo Translational Research and Biomarkers 06 August 2011 Pages: 1713 - 1719
Erratum to: Novel C-terminal Hsp90 Inhibitor for Head and Neck Squamous Cell Cancer (HNSCC) with in vivo Efficacy and Improved Toxicity Profiles Compared with Standard Agents Stephanie M. CohenRidhwi MukerjiMark S. Cohen Erratum 07 March 2012 Pages: 1720 - 1720